Dual RAAS suppression: recent developments and implications in light of the ALTITUDE study

RAAS Working Group. Introducing the RAAS Working Group. J RAAS 2010; 12: 123.

U.S. Food and Drug Administration. FDA Drug Safety Communication: new warning and contraindication for blood pressure medicines containing aliskiren (Tekturna), http://www.fda.gov/drugs/drugsafety/ucm300889.htm (accessed 28 April 2012).

Richer-Giudicelli C Domergue V Gonzalez M-F . Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt. J Hypertens 2004; 22: 619–627.

Danser AHJ van Kesteren CAM Bax WA . Prorenin, renin, angiotensinogen, and angiotensin-converting enzyme in normal and failing human hearts. Evidence for renin binding. Circulation 1997; 96: 220–226.

Klotz S Burkhoff D Garrelds IM . The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur Heart J 2009; 30: 805–812.

Volpe M Tocci G Bianchini F . Use of aliskiren in a ‘real-life’ model of hypertension management: analysis of national Web-based drug-monitoring system in Italy. J Hypertens 2012; 30: 194–203.

Volpe M Danser AHJ Ménard J . Inhibition of the renin-angiotensin-aldosterone system: is there room for dual blockade in the cardiorenal continuum? J Hypertens 2012; 30: 647–654.

Kuenzli A Bucher HC Anand I . Meta-analysis of combined therapy with angiotensin receptor antagonists versus ACE inhibitors alone in patients with heart failure. PLoS One 2010; 5: e9946.

Messerli FH Staessen JA Zannad F . Of fads, fashion, surrogate endpoints and dual RAS blockade. Eur Heart J 2010; 31: 2205–2208.

Schroten NF Gaillard CA van Veldhuisen DJ . New roles for renin and prorenin in heart failure and cardiorenal crosstalk. Heart Fail Rev 2012; 17: 191–201.

Szymanski MK Damman K van Veldhuisen DJ . Prognostic value of renin and prorenin in heart failure patients with decreased kidney function. Am Heart J 2011; 162: 487–493.

McMurray JJ Pitt B Latini R . Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure. Circ Heart Fail 2008; 1: 17–24.

Solomon SD Shin SH Shah A . Effect of the direct renin inhibitor aliskiren on left ventricular remodelling following myocardial infarction with systolic dysfunction. Eur Heart J 2011; 32: 1227–1234.

McMurray JJ Abraham WT Dickstein K . Aliskiren, ALTITUDE, and the implications for ATMOSPHERE. Eur J Heart Fail 2012; 14: 341–343.

Azizi M Ménard J . Renin inhibitors and cardiovascular and renal protection: an endless quest? Cardiovasc Drugs Ther. Epub ahead of print 06 March 2012.